Our editors are on-site at the International Association for the Study of Lung Cancer's 2024 World Conference on Lung Cancer in San Diego to bring you the latest updates on lung cancer treatment and research from the meeting.
Lung Cancers Today
A new medical news property for practicing oncologists treating lung malignancies, Lung Cancers Today features breaking news, commentary, expert interviews, and more.
Advertisement
Researchers presented an updated safety and efficacy analysis at the ESMO 2024 Congress.
The trial is evaluating perioperative pembrolizumab plus sacituzumab govitecan for certain patients with NSCLC.
Researchers shared an updated safety analysis from the trial at the IASLC 2024 World Conference on Lung Cancer.
The KEYNOTE-483 trial showed a significant improvement in OS with the addition of pembrolizumab to chemotherapy.
Dr. Li discusses important thoracic oncology data presented at the ESMO 2024 Congress, which was held in Barcelona, Spain
Ken Culver, MD, Director of Research and Clinical Affairs at ALK Positive, discusses the on-going ALK Life Study.
Benjamin Besse, MD, PhD, shares insights from the research he presented as a late-breaking abstract at ESMO 2024.
The subcutaneous injection is now approved for all adult indications of the intravenous formulation of atezolizumab
Dr. Halmos weighs in on HARMONi-2, TROPION-Lung 01, the SOHO-01 and Beamion LUNG-1 studies, and more.
The study evaluated multiple prophylactic strategies to mitigate infusion-related reactions with IV amivantamab.
Advertisement
Roundtable Discussions on Lung Cancer
Expert Interviews on Lung Cancer
Conference Coverage
Find the latest news and updates on lung cancer from the ESMO Congress 2024.
Find the latest updates on lung cancer treatment and research from the IASLC 2024 World Conference on Lung Cancer.
Find the latest updates on lung cancer treatment and research from the 2024 ASCO Annual Meeting.
Our editors detail the latest data and innovations in the lung cancer space presented at ATS 2024.
Our editors deliver in-depth coverage of NACLC 2023, a premier event offering the latest data on lung cancer advancements.
Our editors provide comprehensive coverage of ESMO Congress 2023, with a focus on lung cancer.
Our editors detail the latest data and innovations in the lung cancer space, as presented at WCLC 2023.
